HubSpot Implementation & Training for a Pharmaceutical Engagement Platform

Company Overview

This engagement involved a UK-based technology platform that serves the pharmaceutical industry by facilitating engagement between pharmaceutical companies and healthcare professionals. The platform acts as an intermediary, connecting pharma organizations with the medical practitioners who influence prescribing decisions, clinical adoption, and product awareness.

Operating in a highly regulated and relationship-driven industry, the company needed to manage a complex web of stakeholders — from large pharmaceutical enterprises to individual healthcare professionals across multiple specialties and regions. As the platform grew, it became clear that managing these relationships through informal processes and disconnected tools was no longer sustainable.

The Challenge

The company faced a set of interconnected challenges that were limiting its ability to scale operations and demonstrate value to both sides of its marketplace.

No Centralized Relationship Management

At the core of the problem was the absence of a CRM. The team was managing pharma company relationships, healthcare professional contacts, and partnership details across a patchwork of spreadsheets, email threads, and internal documents. This made it difficult to maintain a complete picture of any given relationship — who had been contacted, what stage a partnership was in, which healthcare professionals had been engaged, and what follow-up actions were pending.

In the pharmaceutical industry, where compliance and documentation are paramount, this lack of centralized record-keeping introduced both operational inefficiency and risk. If a team member left or was unavailable, critical relationship context could be lost entirely.

Lead Generation and Partner Management Gaps

The company's growth depended on its ability to attract new pharmaceutical partners while simultaneously expanding its network of healthcare professionals. However, without a structured pipeline or lead management process, inbound interest was handled reactively. There was no systematic way to track where a potential partner was in the evaluation process, what their specific engagement needs were, or when follow-up was due.

Similarly, engagement tracking for healthcare professionals — a key metric for demonstrating platform value to pharma clients — was manual and inconsistent. The team knew engagement was happening but lacked the data infrastructure to quantify it, report on it, or use it to drive strategic decisions.

Team Readiness

Beyond the tooling gap, the team needed training. Even with a CRM in place, adoption would only succeed if every team member understood how to use the system consistently. Previous attempts to introduce operational tools had stalled because of insufficient onboarding, making it clear that implementation alone would not be enough — structured training was essential.

Our Approach

We designed the engagement around three pillars: CRM implementation, team enablement, and go-to-market tool evaluation. This structure ensured that the company would not only have the right systems in place but would also have the knowledge and strategic context to use them effectively.

HubSpot CRM Implementation

We began by configuring HubSpot CRM to match the company's unique operational model. Unlike a typical B2B sales environment, this platform needed to manage two distinct relationship types simultaneously: pharmaceutical companies (the revenue-generating partners) and healthcare professionals (the engagement network that delivers value to those partners).

This required thoughtful contact segmentation. We established separate property structures, list definitions, and pipeline configurations for each stakeholder group. Pharma company records were organized around partnership stages — from initial outreach through contract negotiation to active engagement. Healthcare professional records were structured around specialty, region, engagement history, and availability for pharma-sponsored activities.

We also configured the portal for email marketing segmentation, enabling the team to send targeted communications to different audience segments without manual list building. This was particularly important for healthcare professional engagement, where messaging needs to be tailored by specialty, geography, and prior interaction history.

Pipeline Setup and Deal Management

We built deal pipelines that reflected the company's actual sales process — not a generic template. For pharmaceutical partnerships, this meant defining stages that accounted for the extended evaluation cycles typical in the pharma industry, including compliance review, pilot engagement, and contract finalization. Each stage was mapped to specific actions and criteria, giving the team clarity on what needed to happen to move a deal forward.

Team Training

Training was delivered with a focus on practical, day-to-day usage rather than abstract feature overviews. We walked the team through their specific workflows — how to log a new pharma lead, how to update a healthcare professional's engagement record, how to move a deal through the pipeline, and how to pull reports for leadership reviews. The emphasis was on building habits that would sustain long-term CRM adoption rather than one-time feature awareness.

We also created reference materials the team could consult after the training sessions, reducing reliance on external support for routine questions.

Clay Demo and GTM Evaluation

As part of the broader go-to-market conversation, we conducted a demonstration of Clay — a data enrichment and outbound automation platform. The objective was to evaluate whether Clay could enhance the company's lead generation capabilities, particularly for identifying and qualifying new pharmaceutical partners. We walked the team through Clay's enrichment workflows, data sourcing capabilities, and integration points with HubSpot, providing an honest assessment of where Clay would add value versus where it might introduce unnecessary complexity for the company's current stage.

Tech Stack

• HubSpot CRM — Primary platform for managing pharma company partnerships, healthcare professional relationships, deal pipelines, and segmented email communications
• Clay — Evaluated as a potential addition to the go-to-market stack for lead enrichment and prospecting automation

Key Deliverables

• Configured HubSpot portal — Custom properties, segmented contact structures, and deal pipelines tailored to pharmaceutical partnership and healthcare professional engagement workflows
• Contact segmentation for email marketing — List structures and property-based segmentation enabling targeted communications to distinct stakeholder groups
• Team training — Hands-on training sessions covering daily CRM workflows, pipeline management, and reporting, with supporting reference documentation
• Clay demonstration — A structured evaluation of Clay's capabilities in the context of the company's GTM strategy, including integration considerations with HubSpot

Business Outcomes

The most impactful outcome was 100% CRM adoption across the team following the training sessions. Every team member transitioned from their previous ad-hoc processes to consistent HubSpot usage, which is a threshold many organizations struggle to reach even months after implementation. This adoption rate was a direct result of the training-first approach — the team understood not just how to use the tool, but why each workflow mattered to their daily responsibilities.

With HubSpot in place, the company gained the ability to manage pharma relationships and healthcare professional engagement from a single, centralized platform. The fragmentation that had previously characterized their operations — scattered spreadsheets, undocumented conversations, inconsistent follow-ups — was replaced with structured pipelines, logged activity, and searchable records.

The team is now equipped to manage these complex, multi-stakeholder relationships independently. The combination of a properly configured CRM and practical training means the organization can scale its partner network and engagement activities without proportionally increasing operational overhead.

The Clay evaluation gave leadership a clear understanding of how data enrichment tools could fit into their stack as the company matures its outbound capabilities, providing a roadmap for future GTM investment without committing to premature tooling.

Why This Engagement Matters

Technology platforms that operate in regulated industries like pharmaceuticals face unique CRM challenges. The relationships are complex, the compliance requirements are stringent, and the stakeholder groups have fundamentally different needs and communication preferences. A generic CRM setup will not capture these nuances — and without proper training, even a well-configured system will go unused.

This engagement demonstrates that successful CRM adoption is as much about enablement and context as it is about configuration. By investing equally in system setup and team training, the company achieved full adoption from day one — a result that positions them for sustainable, organized growth in a demanding industry.